CLASS II Device recall · Reported 4 May 2022 · FDA Enforcement Report

RocheDiabetes Care Platform recalled

Roche Diabetes Care is recalling RocheDiabetes Care Platform, distributed nationwide in the US. The recall was initiated on 9 Mar 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesDate of manufacture: 2021-11
Quantity recalled81 registered accounts

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1008-2022
FDA event ID
89898
Recalling firm
Roche Diabetes Care, Indianapolis, IN
Classification
Class II
Status
Terminated
Recall initiated
9 Mar 2022
FDA classified
26 Apr 2022
Reported
4 May 2022
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction
Device type
Medical Software

Timeline

9 Mar 2022Recall initiated by company
26 Apr 2022Classified by FDA+48 days
4 May 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for patient data mismatch when using browser "back" button to navigate between patients when using the diabetes management software.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

RocheDiabetes Care Platform Software version 2.5.2 material number 08888353001. This is a web application software hosted on a server. There is no physical product.

Where it was distributed

US Nationwide Distribution: AK, AZ, CA, CO, DC, FL, GA, IL, IN, MN, NC, NJ, NY, PA, RI, SC, TX, WI

Nationwide AlaskaArizonaCaliforniaColoradoDistrict of ColumbiaFloridaGeorgiaIllinoisIndianaMinnesotaNorth CarolinaNew JerseyNew YorkPennsylvaniaRhode IslandSouth CarolinaTexasWisconsin

Questions about this recall

Why was it recalled?

Potential for patient data mismatch when using browser "back" button to navigate between patients when using the diabetes management software.

Which lots are affected?

Date of manufacture: 2021-11

Where was it sold?

US Nationwide Distribution: AK, AZ, CA, CO, DC, FL, GA, IL, IN, MN, NC, NJ, NY, PA, RI, SC, TX, WI

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Diabetes Care

All 29

Other Medical Software recalls

All 933